CLOV Stock Price Increases Over 5% Intraday: Why It Happened

CLOV Stock Price Increases Over 5% Intraday: Why It Happened
  • The stock price of Clover Health Investments Corp (NASDAQ: CLOV) increased by over 5% during intraday trading. This is why it happened.

The stock price of Clover Health Investments Corp (NASDAQ: CLOV) – an innovative technology company committed to improving health equity for America’s underserved seniors – increased by over 5% during intraday trading. Investors are responding positively to Clover Health announcing a strategic partnership with ValueH, a leading member organization focused on Value-Based Care. And through the arrangement, ValueH will support Accountable Care Organizations (ACOs) and Management Services Organizations (MSOs) participating in Clover’s Direct Contracting Entity beginning in 2022.

Clover’s DCE will enable providers to manage the care of their Original Medicare patients with the Clover Assistant. And the Clover Assistant is a clinical software tool used by doctors at the point of care to provide them with data-driven personalized recommendations to improve how they care for their patients. And participating providers can benefit from:

— Unified, Actionable Data — Access lab results, prescription lists, and previous diagnoses, including those from other clinicians

— Personalized Care Plans — Receive and share new information at each patient visit and have access to clinical decision support

— Simple, Fast Reimbursement — Receive the Clover Assistant reimbursement within seven days for each patient seen with the Clover Assistant

Clover Health Partners has seen significant traction as a Direct Contracting Entity since it started participating in the Centers for Medicare & Medicaid Services’ Global and Professional Direct Contracting Model. And as of April 1, 2021, it had contracted with approximately 1,800 individual providers across eight states and had over 65,000 claims aligned beneficiaries.


“We are excited to partner with ValueH to help support our efforts to increase the quality of care delivered to patients while simultaneously lowering medical costs. We believe Direct Contracting has the potential to increase the growth of value-based models, specifically for the Medicare population.”

— Kevin Murphy, Executive Director of Clover Health Partners

“The team at ValueH has deep experience with value-based care, best practices, and enablement services that they share with Florida accountable care organizations and managed care organization leaders. Our partnership with Clover allows us to continue to champion independent practices while enhancing each entity’s ability to make measurable improvements in care.”

— Kelly Conroy, Chief Executive Officer of ValueH

Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.